Compare CBUS & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBUS | PCF |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.1M | 107.4M |
| IPO Year | 2017 | 1994 |
| Metric | CBUS | PCF |
|---|---|---|
| Price | $1.51 | $5.68 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 799.0K | 77.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,639,000.00 | N/A |
| Revenue This Year | $112.72 | N/A |
| Revenue Next Year | $83.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $5.36 |
| 52 Week High | $4.19 | $6.51 |
| Indicator | CBUS | PCF |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 52.34 |
| Support Level | $1.46 | $5.39 |
| Resistance Level | $1.59 | $5.69 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 31.88 | 64.29 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.